Cognitive performance and brain structural connectome alterations in major depressive disorder.

cognitive performance connectomics depressive symptoms graph theory processing speed tractography

Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
08 Feb 2023
Historique:
entrez: 8 2 2023
pubmed: 9 2 2023
medline: 9 2 2023
Statut: aheadofprint

Résumé

Cognitive dysfunction and brain structural connectivity alterations have been observed in major depressive disorder (MDD). However, little is known about their interrelation. The present study follows a network approach to evaluate alterations in cognition-related brain structural networks. Cognitive performance of All cognitive factors were associated with global connectivity strength. For each cognitive factor, network-based statistics identified a subnetwork of connections, revealing, for example, a subnetwork positively associated with processing speed. Within that subnetwork, acutely depressed patients showed significantly reduced connectivity strength compared to healthy controls. Moreover, connectivity strength in that subnetwork was associated to current depressive symptom severity independent of the previous disease course. Our study is the first to identify cognition-related structural brain networks in MDD patients, thereby revealing associations between cognitive deficits, depressive symptoms, and reduced structural connectivity. This supports the hypothesis that structural connectome alterations may mediate the association of cognitive deficits and depression severity.

Sections du résumé

BACKGROUND BACKGROUND
Cognitive dysfunction and brain structural connectivity alterations have been observed in major depressive disorder (MDD). However, little is known about their interrelation. The present study follows a network approach to evaluate alterations in cognition-related brain structural networks.
METHODS METHODS
Cognitive performance of
RESULTS RESULTS
All cognitive factors were associated with global connectivity strength. For each cognitive factor, network-based statistics identified a subnetwork of connections, revealing, for example, a subnetwork positively associated with processing speed. Within that subnetwork, acutely depressed patients showed significantly reduced connectivity strength compared to healthy controls. Moreover, connectivity strength in that subnetwork was associated to current depressive symptom severity independent of the previous disease course.
CONCLUSIONS CONCLUSIONS
Our study is the first to identify cognition-related structural brain networks in MDD patients, thereby revealing associations between cognitive deficits, depressive symptoms, and reduced structural connectivity. This supports the hypothesis that structural connectome alterations may mediate the association of cognitive deficits and depression severity.

Identifiants

pubmed: 36752136
doi: 10.1017/S0033291722004007
pii: S0033291722004007
pmc: PMC10600941
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-12

Subventions

Organisme : EPA
ID : EP-C-16-015
Pays : United States

Références

J Clin Psychiatry. 2008 Jul;69(7):1122-30
pubmed: 18572982
Neuroimage Clin. 2021;30:102677
pubmed: 34215148
J Affect Disord. 2016 Jan 1;189:184-91
pubmed: 26437233
PLoS One. 2017 May 15;12(5):e0177727
pubmed: 28505177
Psychiatry Res. 2010 Apr 30;176(2-3):183-9
pubmed: 20138370
Psychiatry Res. 2014 Aug 30;218(3):261-71
pubmed: 24851725
Neuroimage. 2010 Sep;52(3):1059-69
pubmed: 19819337
Psychometrika. 1965 Jun;30:179-85
pubmed: 14306381
Mol Psychiatry. 2020 Jul;25(7):1550-1558
pubmed: 31758093
Neuroimage. 2012 May 1;60(4):2182-90
pubmed: 22487548
Eur Arch Psychiatry Clin Neurosci. 2019 Dec;269(8):949-962
pubmed: 30267149
Front Psychiatry. 2015 Feb 18;6:21
pubmed: 25762941
NMR Biomed. 2002 Nov-Dec;15(7-8):587-93
pubmed: 12489105
Psychol Med. 2014 Jul;44(10):2029-40
pubmed: 24168753
Hum Brain Mapp. 2011 Dec;32(12):2161-71
pubmed: 21170955
BMC Neurol. 2012 Oct 30;12:126
pubmed: 23110387
PLoS One. 2014 Feb 28;9(2):e90311
pubmed: 24587318
Psychol Med. 2011 Jun;41(6):1165-74
pubmed: 20932356
Lancet Psychiatry. 2019 Apr;6(4):318-326
pubmed: 30904126
Hum Brain Mapp. 2018 Feb;39(2):622-632
pubmed: 29139161
Psychiatry Res. 2006 Nov 29;145(1):39-48
pubmed: 17045658
Lancet Neurol. 2008 Dec;7(12):1139-51
pubmed: 19007738
Neuroimage. 2023 Jun;273:120108
pubmed: 37059156
Biophys J. 1994 Jan;66(1):259-67
pubmed: 8130344
Front Neurol. 2021 Jul 08;12:671894
pubmed: 34305785
J Affect Disord. 2015 Mar 15;174:542-8
pubmed: 25556672
Neuroimage. 2010 Dec;53(4):1197-207
pubmed: 20600983
Acta Psychiatr Scand. 2008 Dec;118(6):451-8
pubmed: 18853945
Bipolar Disord. 2017 Feb;19(1):23-31
pubmed: 28239946
J Psychiatry Neurosci. 2017 May;42(3):150-163
pubmed: 27780031
Neuroimage. 2017 Aug 1;156:394-402
pubmed: 28549795
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Neuroimage. 2018 May 15;172:450-460
pubmed: 29410079
Mol Psychiatry. 2017 Apr;22(4):527-536
pubmed: 27528460
Depress Anxiety. 2013 Jun;30(6):515-27
pubmed: 23468126
Hum Brain Mapp. 2020 Oct 15;41(15):4397-4405
pubmed: 32648625
Mol Psychiatry. 2020 Jul;25(7):1511-1525
pubmed: 31471575
Br J Psychiatry. 2016 Jun;208(6):585-90
pubmed: 26892846
J Clin Exp Neuropsychol. 2019 Nov;41(9):913-924
pubmed: 31437083
J Psychiatry Neurosci. 2019 May 16;44(6):407-413
pubmed: 31094489
Neuroimage. 2016 Nov 15;142:407-420
pubmed: 27364472
Int J Geriatr Psychiatry. 2010 Oct;25(10):933-44
pubmed: 20872927
Brain. 2020 Apr 1;143(4):1158-1176
pubmed: 32243506
J Affect Disord. 2017 Nov;222:103-111
pubmed: 28688263
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Biol Psychiatry. 2006 Sep 1;60(5):472-8
pubmed: 16483550
JAMA Psychiatry. 2014 Nov;71(11):1222-30
pubmed: 25188810
Lancet Psychiatry. 2019 Oct;6(10):851-861
pubmed: 31422920
Neurosci Bull. 2021 Jun;37(6):863-880
pubmed: 33582959
J Neurosci. 2018 Nov 7;38(45):9658-9667
pubmed: 30249801
J Neurophysiol. 2016 Nov 1;116(5):2093-2104
pubmed: 27512019
Brain. 2018 Sep 1;141(9):2605-2618
pubmed: 30169585
Biol Mood Anxiety Disord. 2011 Sep 27;1(1):3
pubmed: 22738088
Radiology. 2015 Apr;275(1):89-96
pubmed: 25426773
Transl Psychiatry. 2016 Jun 07;6(6):e835
pubmed: 27271861
J Neurosci Methods. 2012 Jan 30;203(2):386-97
pubmed: 22001222
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 May;1(3):209-217
pubmed: 27453952
J Affect Disord. 2021 Apr 1;284:238-246
pubmed: 33631438
Trends Cogn Sci. 2013 Dec;17(12):683-96
pubmed: 24231140
Int J Neuropsychopharmacol. 2015 Jul 25;19(2):
pubmed: 26209859
Neuroimage. 2013 Apr 15;70:402-9
pubmed: 23296185
Hum Brain Mapp. 2021 Jul;42(10):3102-3118
pubmed: 33830577
Hum Brain Mapp. 2017 Feb;38(2):803-816
pubmed: 27726264
Neuropsychol Rev. 2018 Mar;28(1):32-72
pubmed: 29446012
J Affect Disord. 2014 Feb;155:42-8
pubmed: 24210630

Auteurs

Marius Gruber (M)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Goethe University, 60528 Frankfurt, Germany.

Marco Mauritz (M)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Susanne Meinert (S)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.
Institute of Translational Neuroscience, University of Münster, 48149 Münster, Germany.

Dominik Grotegerd (D)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Siemon C de Lange (SC)

Connectome Lab, Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, 1081 HV Amsterdam, The Netherlands.
Department of Sleep and Cognition, Netherlands Institute for Neuroscience, an institute of the Royal Netherlands Academy of Arts and Sciences, 1105 BA Amsterdam, The Netherlands.

Pascal Grumbach (P)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Janik Goltermann (J)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Nils Ralf Winter (NR)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Lena Waltemate (L)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Hannah Lemke (H)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Katharina Thiel (K)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Alexandra Winter (A)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Fabian Breuer (F)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Tiana Borgers (T)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Verena Enneking (V)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Melissa Klug (M)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Katharina Brosch (K)

Department of Psychiatry and Psychotherapy, University of Marburg, 35039 Marburg, Germany.
Center for Mind, Brain and Behavior, University of Marburg, 35032 Marburg, Germany.

Tina Meller (T)

Department of Psychiatry and Psychotherapy, University of Marburg, 35039 Marburg, Germany.
Center for Mind, Brain and Behavior, University of Marburg, 35032 Marburg, Germany.

Julia-Katharina Pfarr (JK)

Department of Psychiatry and Psychotherapy, University of Marburg, 35039 Marburg, Germany.
Center for Mind, Brain and Behavior, University of Marburg, 35032 Marburg, Germany.

Kai Gustav Ringwald (KG)

Department of Psychiatry and Psychotherapy, University of Marburg, 35039 Marburg, Germany.
Center for Mind, Brain and Behavior, University of Marburg, 35032 Marburg, Germany.

Frederike Stein (F)

Department of Psychiatry and Psychotherapy, University of Marburg, 35039 Marburg, Germany.
Center for Mind, Brain and Behavior, University of Marburg, 35032 Marburg, Germany.

Nils Opel (N)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.
Department of Psychiatry, Jena University Hospital/Friedrich-Schiller-University Jena, 07743 Jena, Germany.

Ronny Redlich (R)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.
Institute of Psychology, University of Halle, 06108 Halle (Saale), Germany.

Tim Hahn (T)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Elisabeth J Leehr (EJ)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Jochen Bauer (J)

Department of Radiology, University of Münster, 48149 Münster, Germany.

Igor Nenadić (I)

Department of Psychiatry and Psychotherapy, University of Marburg, 35039 Marburg, Germany.
Center for Mind, Brain and Behavior, University of Marburg, 35032 Marburg, Germany.

Tilo Kircher (T)

Department of Psychiatry and Psychotherapy, University of Marburg, 35039 Marburg, Germany.
Center for Mind, Brain and Behavior, University of Marburg, 35032 Marburg, Germany.

Martijn P van den Heuvel (MP)

Connectome Lab, Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, 1081 HV Amsterdam, The Netherlands.
Department of Child Psychiatry, Amsterdam University Medical Center, Amsterdam Neuroscience, 1105 AZ Amsterdam, The Netherlands.

Udo Dannlowski (U)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.

Jonathan Repple (J)

Institute for Translational Psychiatry, University of Münster, 48149 Münster, Germany.
Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Goethe University, 60528 Frankfurt, Germany.

Classifications MeSH